Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

1,986

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Major Depressive Disorder
Interventions
DRUG

Placebo

Once daily, tablets, orally

DRUG

Brexpiprazole

1, 2, or 3 mg/day, once daily dose, tablets, orally. Uptitration in weekly steps from 1 mg/day

DRUG

ADT

Duloxetine, escitalopram, fluoxetine, paroxetine IR, sertraline, venlafaxine XR; dosing according to label

Trial Locations (107)

Unknown

US041, Little Rock

US043, Cerritos

US042, Temecula

US053, Flowood

US040, Brooklyn

US046, Houston

US052, Houston

US047, Milwaukee

BG007, Kardzhali

BG002, Pazardzhik

BG003, Rousse

BG001, Sofia

BG004, Sofia

BG005, Varna

BG006, Varna

CA003, Burlington

CA004, Edmonton, Alberta

CA001, Kingston

CA002, Montral

CA005, Montreal

EE002, Tallinn

EE003, Tallinn

EE006, Tallinn

EE001, Tartu

EE005, Tartu

EE004, Võru

FI002, Helsinki

FI003, Helsinki

FI006, Helsinki

FI001, Kuopio

FI007, Pori

FI009, Tampere

DE007, Berlin

DE014, Berlin

DE015, Berlin

DE006, Bielefeld

DE010, Bochum

DE012, Gelsenkirchen

DE009, Hanover

DE022, Hattingen

DE008, Heidelberg

DE017, Leipzig

DE001, Nuremberg

DE004, Nuremberg

DE002, Schwerin

DE016, Wiesbaden

LV004, Daugavpils

LV005, Jelgava

LV002, Liepāja

LV003, Riga

LV001, Strenči

LT003, Kaunas

LT006, Kaunas Region

LT001, Palanga

LT005, Šilutė

LT002, Vilnius

LT004, Vilnius

MX009, Guadalajara

MX008, León

MX002, Monterrey

MX003, Monterrey, Nuevo Len

PL010, Bialystok

PL016, Bialystok

PL017, Bydgoszcz

PL007, Chełmno

PL002, Gdansk

PL011, Gorlice

PL018, Kielce

PL013, Leszno

PL001, Lublin

PL006, Lublin

PL014, Szczecin

PL012, Torun

PL019, Torun

RO003, Bucharest

RO006, Bucharest

RO001, Iași

RO004, Timișoara

RU002, Moscow

RU004, Moscow

RU003, Saint Petersburg

RU006, Saint Petersburg

RU007, Saint Petersburg

RU010, Saint Petersburg

RU014, Saint Petersburg

RU012, Saratov

RU005, Stavropol

KR001, Seoul

KR004, Seoul

SE008, Halmstad

SE006, Malmo

SE009, Skövde

SE001, Stockholm

UA006, Kharkiv

UA007, Kherson,Vil. Stepanivka

UA003, Kiev

UA014, Kiev

UA002, Kyiv

UA005, Lviv

UA012, Ternopil

UA009, Vinnytsia

GB003, Blackpool

GB005, Bognor Regis

GB002, Bradford

GB004, Cannock

GB001, Leeds

GB006, Winwick

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

H. Lundbeck A/S

INDUSTRY